Amity University confers honorary doctorate on Thumbay Moideen

coastaldigest.com news network
November 21, 2017

Dubai, Nov 21: Thumbay Moideen, the Founder President of Dubai-based global conglomerate Thumbay Group, was conferred an Honorary Doctorate at the annual convocation ceremony of Amity University – Dubai, on November 20. Mr. Moideen, the Guest of Honour of the convocation ceremony, was awarded the doctorate in the presence of distinguished dignitaries, academicians, students, teachers and parents.

An official statement by Amity University Dubai said that Mr.ThumbayMoideen was being conferred the honor in view of his “significant contributions towards promotion of medical education, trade and industry, and social and economic development of the nation.”

In his acceptance speech, Mr. Thumbay Moideen expressed his gratitude to Amity University Dubai for awardingthe doctorate. “Throughout my career, I have had the privilege of transforming lives through education and healthcare, strengthening communities and contributing to the growth and progress of the nation. I owe my success to God Almighty, the support of the government, and my team. This recognition will inspire me to do more in driving positive change,” he said.

Mr. Thumbay Moideen awarded certificates to the graduates and the honors for batch toppers.

About Mr. Thumbay Moideen

Mr. ThumbayMoideen is the Founder President of Thumbay Group, a diversified international conglomerate headquartered at DIFC - Dubai, United Arab Emirates (UAE). Starting with the establishment of Thumbay Group in 1998, he has set up business operations in 20 sectors. Today, the Group has activities in Education, Healthcare, Medical Research, Diagnostics, Retail Pharmacy, Health Communications, Retail Optical, Wellness, Nutrition Stores, Hospitality, Real Estate, Publishing, Technology, Media, Events, Medical Tourism, Trading and Marketing & Distribution.

Thumbay Group today employs close to 5000 people, which is projected to increase to around 25000 by the year 2022, with the completion of ongoing and upcoming projects. The Thumbay chain of hospitals, the constituent teaching hospitals of the Gulf Medical University are one of the largest healthcare services providers in the UAE, serving patients from over 175 nationalities. The Gulf Medical University (GMU) which is one of the leading private medical universities in the Middle East region, attracts a student cohort of 80 nationalities and faculty and staff from over 25 countries. Currently, Thumbay Group is focusing on its strategic long-term plans which will see the group scale its businesses almost ten times and expand its operations globally.

The Group plans to build three more international campuses in the next five years. This is in addition to the plans to expand the chain of academic hospitals to 15 worldwide by 2022, with a total capacity of 1000 beds in the UAE, 1500 beds in India and 750 beds elsewhere in the Gulf and in Africa. The group also plans to expand specialized retail outlets.

Comments

ABDUL SALAM BELMA
 - 
Wednesday, 22 Nov 2017

All the best, congrats to well deserved person

Ahmed Bava
 - 
Tuesday, 21 Nov 2017

Masha Allah Mabrook Mr.Moideen Thumbay

AR Shetty
 - 
Tuesday, 21 Nov 2017

Hearty Congratulations saab

Muhammed Ali Uchil
 - 
Tuesday, 21 Nov 2017

Great honor-A Doctorate from World reputed Amity University-

thanks for  choosing the  right and most deserved person for 

this Privilege .

 

Heartily Congratulations Moideen Saab.

Danish
 - 
Tuesday, 21 Nov 2017

Wow. great! All the best for your future ventures..

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 8,2020

New Delhi, Jul 8: India has reported a spike of 22,752 COVID-19 cases in the last 24 hours, taking the country's coronavirus tally to 7,42,417 on Wednesday, informed the Union Ministry of Health and Family Welfare.

Out of the total cases reported, 4,56,830 patients have been cured/discharged from the disease while one patient has been migrated, the Health Ministry informed.

It added that there are 2,64,944 active cases in the country.

482 deaths reported in the last 24 hours due to COVID-19 in the country, taking India's death toll to 20,642.

According to the Union Health Ministry, Maharashtra continues to be the worst affected state reporting 2,17,121 coronavirus cases and 9,250 fatalities.

Tamil Nadu -- the second worst-affected state from COVID-19 -- has a total of 1,18,594 cases and 1,636 deaths due to coronavirus.

While Delhi has a total of 1,02,831 COVID-19 cases including 3,165 deaths.

The Indian Council of Medical Research on Wednesday informed that a total of 1,04,73,771 samples tested for COVID-19 up to July 7. Of these, 2,62,679 samples were tested on Tuesday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 1,2020

Mangaluru, Feb 2: A video of a woman rescuing a dog from a well in Mangaluru has gone viral on social media. The dog fell inside the well accidentally and the woman rushed to the spot to rescue it. The two minute seven second video has been shared on Twitter by a user, Mauna, and has ever since been viewed over 15,000 times.

The woman climbed down the well as other people attached a rope to her body during the rescue mission. Another rope was then thrown to her and she tied it around the dog after which it was pulled outside. The woman, thereafter, climbed outside the well with much difficulty.

"Bless the lady who saved the Dog," the user captioned the post.

Watch the video here:

 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.